Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

J Biol Chem 2010 Jun 31;285(23):17648-61. Epub 2010 Mar 31.

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

Alpha-synuclein (a-Syn), a protein implicated in Parkinson disease, contributes significantly to dopamine metabolism. a-Syn binding inhibits the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Phosphorylation of TH stimulates its activity, an effect that is reversed by protein phosphatase 2A (PP2A). In cells, a-Syn overexpression activates PP2A. Here we demonstrate that a-Syn significantly inhibited TH activity in vitro and in vivo and that phosphorylation of a-Syn serine 129 (Ser-129) modulated this effect. In MN9D cells, a-Syn overexpression reduced TH serine 19 phosphorylation (Ser(P)-19). In dopaminergic tissues from mice overexpressing human a-Syn in catecholamine neurons only, TH-Ser-19 and TH-Ser-40 phosphorylation and activity were also reduced, whereas PP2A was more active. Cerebellum, which lacks excess a-Syn, had PP2A activity identical to controls. Conversely, a-Syn knock-out mice had elevated TH-Ser-19 phosphorylation and activity and less active PP2A in dopaminergic tissues. Using an a-Syn Ser-129 dephosphorylation mimic, with serine mutated to alanine, TH was more inhibited, whereas PP2A was more active in vitro and in vivo. Phosphorylation of a-Syn Ser-129 by Polo-like-kinase 2 in vitro reduced the ability of a-Syn to inhibit TH or activate PP2A, identifying a novel regulatory role for Ser-129 on a-Syn. These findings extend our understanding of normal a-Syn biology and have implications for the dopamine dysfunction of Parkinson disease.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.100867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878529PMC
June 2010
15 Reads

Publication Analysis

Top Keywords

a-syn
14
vitro vivo
12
a-syn overexpression
8
parkinson disease
8
protein phosphatase
8
vivo phosphorylation
8
phosphorylation a-syn
8
pp2a active
8
phosphorylation activity
8
a-syn ser-129
8
dopaminergic tissues
8
tyrosine hydroxylase
8
cells a-syn
8
serine 129
8
phosphorylation
7
pp2a
7
activity
6
serine phosphorylation
4
mimic serine
4
reduced serine
4

References

(Supplied by CrossRef)

Maroteaux et al.
J. Neurosci. 1988

Baptista et al.
J. Neurochem. 2003

Similar Publications